Author name: Claritas Rx

Do you have the tools and processes necessary to protect patient data? Here’s what to consider.

Collaborative patient management and care can reduce time to treatment and boost health outcomes for patients.

The Inflation Reduction Act contains provisions that affect drug pricing. Here’s how pharma companies, payers and providers can respond.

The interoperability of shareable medical data “is the ability of different information systems, devices and applications (systems) to access, exchange, integrate and cooperatively use data in a coordinated manner,” according to the Healthcare Information and Management Systems Society (HIMSS). Interoperable systems can share data across organizational and national boundaries. By doing so, these systems can

Where do rare disease patients find help when they can’t afford treatment and specialty medications? Here, we look at financial assistance options.

Supply chain issues can hinder fulfillment. Data-driven logistics can overcome these challenges.

Supply chain issues are legion, and any can hinder or delay fulfillment — potentially putting patients at risk.

As genetic testing becomes more common, it also generates fruitful data for specialty pharma.

There’s lots of obstacles to ensure patients can access clinically appropriate therapy, and even once they do start treatment, questions arise as to whether they’ll stay on the treatment, and even how effective it is. Solving abandonment and discontinuation in specialty drugs can be nonviable, unless you have the in-depth data to identify the cause,